DOCUMENTS

SAVAC 2.0 immunoassay workshop in Abu Dhabi on 3Nov 2023
  • SAVAC 2.0 workshop for immunoassay_3Nov2023.pdfDownload
List of publications from SAVAC 1.0

SAVAC Protocols in OFID
  • All articlesLink
  • Harmonizing Surveillance Methodologies for Group A Streptococcal DiseasesLink
  • Standardization of Epidemiological Surveillance of Group A Streptococcal Pharyngitis Link
  • Standardization of Epidemiological Surveillance of Group A Streptococcal ImpetigoLink
  • Standardization of Epidemiological Surveillance of Group A Streptococcal CellulitisLink
  • Standardization of Epidemiological Surveillance of Invasive Group A Streptococcal Infections Link
  • Standardization of Epidemiological Surveillance of Acute Rheumatic FeverLink
  • Standardization of Epidemiological Surveillance of Rheumatic Heart DiseaseLink
  • Standardization of Epidemiological Surveillance of Acute Poststreptococcal GlomerulonephritisLink

SAVAC NPJ Vaccines health economics papers
  • Modeling the potential health impact of prospective Strep A vaccinesLink
  • The potential global cost-effectiveness of prospective Strep A vaccines and associated implementation effortsLink
  • Optimal global spending for group A Streptococcus vaccine research and development Link
  • Global economic burden per episode for multiple diseases caused by group A StreptococcusLink
  • A Strep A vaccine global demand and return on investment forecast to inform industry research and development prioritizationLink

NPJ Vaccine pipeline
  • The Streptococcus pyogenes vaccine landscapeLink

Safety paper
  • Safety of Streptococcus pyogenes Vaccines: Anticipating and Overcoming Challenges for Clinical Trials and Post-Marketing MonitoringLink

Immune correlates paper
  • Correlates of immunity to Group A Streptococcus: a pathway to vaccine developmentLink
WHO expert review of Group A Streptococcus vaccines: Hybrid Consultation by IVIR-AC and PDVAC, London, UK, 30 September 2022
  • who-expert-review-of-gas-vx-exec-summary-pdvac-and-ivirac-final.pdfDownload
SAVAC 2nd Stakeholders meeting Report 06JUNE2022
  • SAVAC 2nd Stakeholders meeting Report 06JUNE2022.pdfDownload
Presentation slides at the second SAVAC Stakeholders Meeting, 06 June 2022
  • 1. A strategic approach to understand strep A disease burden_Jonathan Carapetis.pdfDownload
  • 2. Immunologic protection and correlates_Shiranee Sriskandan.pdfDownload
  • 3. Strep A Vaccine Safety Considerations and Guidance during Development_Edwin Asturias.pdfDownload
  • 4. Potential impact of prospective strep A vaccines on the global burden of disease_model based analysis_Kaja Abbas.pdfDownload
  • 5. Global economic burden for Strep A infections and cost effectiveness analysis for a hypothetical Strep A vaccine_Jung Seok Lee.pdfDownload
  • 6. The full health economic social benefits of vaccination_conceptual framework and application to Strep A vaccines_Dan Cadarette.pdfDownload
  • 7. The Effect of a Prospective Vaccine Against Group A Streptococcus on Global Antibiotic Consumption for Sore Throat_Jeff Cannon.pdfDownload
  • 8. Global health and economic benefits _Maddalena Ferranna.pdfDownload
  • 9. Business Case for Industry Investment in Strep A Vaccine R&D_Don Walkinshaw.pdfDownload
  • 10. Optimal Global Spending for Group A Streptococcus Vaccine Research and Development_Dan Tortorice.pdfDownload
SAVAC Stakeholders meeting Report 13JUNE2021
  • SAVAC Stakeholders meeting Report 13JUNE2021.pdfDownload
SAVAC High Level Development Strategy 8MAY2020
  • SAVAC High Level Development Strategy 8MAY2020.pdfDownload
Vekemans WHO GAS vaccine R&D roadmap CID 2019
  • Vekemans WHO GAS vaccine R&D roadmap CID 2019.pdfDownload
WHO-IVB-18.07-WHO Preferred Product Characteristics for GAS Vaccines 2018
  • WHO-IVB-18.07-WHO Preferred Product Characteristics for GAS Vaccines 2018.pdfDownload
WHO-IVB-18.08-GAS Vaccine Develoment Technology Roadmap 2018
  • WHO-IVB-18.08-GAS Vaccine Develoment Technology Roadmap 2018.pdfDownload